FEATURED Executive Interview | Aethlon Medical (AEMD)

In this episode of the Executive Interview Series we speak to Dr. Douglas Taylor, Chief Scientific Officer of Exosome Sciences, wholly owned subsidiary of Aethlon Medical, ticker symbol AEMD.


Executive Interview | Jim Czirr, CEO of Galectin Therapeutics (GALT)

We speak with Mr. Jim Czirr, Executive Chairman of Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer.

Executive Interview | Miraculins (TSX-V: MOM)

We speak with Mr. Christopher Moreau, President and CEO of Miraculins, a biotechnology company focused on diagnostic tests and risk assessment technologies for unmet clinical needs.

Executive Interview | Blue Water Global Group (BLUU)

In this episode we will be talking to Mr. Scott Sitra, CEO of Blue Water Global Group, Inc., a publicly held developer of casual dining restaurant properties and premium distilled spirits..


Technical Analysis | CrowdGather, Inc. (CRWG)

A technical look at CrowdGather's stock following its acquisition of PLAOR and its transition from wholly-owned forum communities to social gaming and hosted forum communities.

Company Spotlight | American DG Energy (ADGE)

Featuring American DG Energy, Inc. (ADGE), an on-site utility company that, distributes, owns, operates, and maintains on-site energy systems. >Read More

Executive Interview | Beamz Interactive (BZIC)

We recently sat down with Beamz Interactive CEO Charlie Mollo >Read More


Executive Interview | The Guitammer Company (GTMM)

Recent developments with The Guitammer Company (GTMM) are discussed, focusing on the Company's recent first-ever live sports broadcast.

Executive Interview | One World Holdings, Inc. (OWOO)

Trent D. Daniel, founder of One World Holdings, Inc. joins us to discuss his business, and what management is doing to build value for shareholders.

Executive Interview | CrowdGather, Inc. (CRWG)

We are joined by seasoned entrepreneur Sanjay Sabnani, Chief Executive Officer of CrowdGather, Inc., one of the leading networks of forum communities on the internet.


Greg Jaclin of Szaferman Lakind

Greg discusses how public companies raise capital via Regulation D.

Ruth Hedges of Unismart Capital Software

Ruth talks about implications of the JOBS act in the immediate and long term.

Mr. Jeffrey Fessler of Sichenzia Ross Friedman Ference

Mr. Fessler discusses options for taking a company public, and the pros and cons of uplisting.

Seth Farbman of VStockTransfer

Seth talks about DTC eligibility, DWAC and other clearing issues.


Industry Focus | Regenerative Medicine | Athersys (NASDAQ: ATHX)

In this Industry Focus we highlight the field of Regenerative Medicine and the 2013 Stem Cell Meeting on The Mesa held in La Jolla, California. The focus of this installment is Athersys, Inc. (NASDAQ: ATHX)

Video News Release | Alliance for Regenerative Medicine

Regenerative medicine offers significant cost savings at a critical time for the healthcare system. With seven cell therapy products approved in 2012 - regulatory agencies are showing a growing appetite for a new approach that should continue to gain momentum over the coming years.